Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van der Ley

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Vaccine|August 13, 2013
Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesiclesAfshin Zariri, Harry van Dijken, Hendrik-Jan Hamstra, et al.
The Journal of Infection|January 8, 2014
Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adultsMignon du Plessis, Nicole Wolter, Penny Crowther-Gibson, et al.
Plos Pathogens|April 25, 2009
Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathyFloris Fransen, Sebastiaan G B Heckenberg, Hendrik Jan Hamstra, et al.
Vaccine|January 9, 2014
Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypesMaría Emilia Gaillard, Daniela Bottero, Agustina Errea, et al.
Plos One|January 5, 2011
Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussisFloris Fransen, Rachel M Stenger, Martien C M Poelen, et al.
Plos One|December 5, 2012
Prevalence and clinical course in invasive infections with meningococcal endotoxin variantsGerwin D Rodenburg, Floris Fransen, Debby Bogaert, et al.
Pharmaceutics|April 30, 2021
Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and ImmunomodulationVirgil Schijns, Dragomira Majhen, Peter van der Ley, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in miceJeroen Geurtsen, H Alexander Banus, Eric R Gremmer, et al.
Infection and Immunity|October 29, 2014
Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cellsJolanda Brummelman, Rosanne E Veerman, Hendrik Jan Hamstra, et al.
Cellular Microbiology|January 31, 2006
Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell functionLiana Steeghs, Sandra J van Vliet, Heli Uronen-Hansson, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Vaccine|August 13, 2013
Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesiclesAfshin Zariri, Harry van Dijken, Hendrik-Jan Hamstra, et al.
The Journal of Infection|January 8, 2014
Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adultsMignon du Plessis, Nicole Wolter, Penny Crowther-Gibson, et al.
Plos Pathogens|April 25, 2009
Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathyFloris Fransen, Sebastiaan G B Heckenberg, Hendrik Jan Hamstra, et al.
Vaccine|January 9, 2014
Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypesMaría Emilia Gaillard, Daniela Bottero, Agustina Errea, et al.
Plos One|January 5, 2011
Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussisFloris Fransen, Rachel M Stenger, Martien C M Poelen, et al.
Plos One|December 5, 2012
Prevalence and clinical course in invasive infections with meningococcal endotoxin variantsGerwin D Rodenburg, Floris Fransen, Debby Bogaert, et al.
Pharmaceutics|April 30, 2021
Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and ImmunomodulationVirgil Schijns, Dragomira Majhen, Peter van der Ley, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in miceJeroen Geurtsen, H Alexander Banus, Eric R Gremmer, et al.
Infection and Immunity|October 29, 2014
Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cellsJolanda Brummelman, Rosanne E Veerman, Hendrik Jan Hamstra, et al.
Cellular Microbiology|January 31, 2006
Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell functionLiana Steeghs, Sandra J van Vliet, Heli Uronen-Hansson, et al.
Pageof 8